Papers

2

Total Citations

8

H-Index

2

About

Pilar Paredes is a leading figure in the intersection of nuclear medicine and precision oncology, with her research primarily focused on advancing molecularly targeted therapies and liquid biopsy techniques for cancer management. Her most impactful work, "Interventional nuclear medicine's contribution to molecularly targeted precision surgery" (2022, 6 citations), highlights her pioneering role in integrating radiopharmaceuticals into surgical workflows, enabling real-time tumor detection and resection. This contribution positions her at the forefront of theranostics, where diagnostic imaging and therapy converge to personalize treatment. Additionally, her 2024 study on the "Role of Liquid Biopsy in Progressive PSA Patients after Radical Prostatectomy" (2 citations) addresses a critical gap in prostate cancer care, demonstrating how circulating free DNA (cfDNA) levels can improve the prediction of biochemical recurrence beyond traditional clinicopathological parameters. By bridging nuclear medicine and molecular diagnostics, Paredes is shaping a new paradigm for precision surgery and postoperative surveillance. Her work, though early in citation impact, signals a transformative approach to cancer care, earning her recognition as an innovator in interventional nuclear medicine and liquid biopsy applications for solid tumors.

Research Focus

Key Achievements

2
H-Index
2
Papers
8
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Interventional nuclear medicine's contribution to molecularly targeted precision surgery
6 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Universitat de Barcelona, Hospital Clínic de Barcelona

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago